Fund shareholders of Amphastar Pharmaceuticals Inc
ISIN US03209R1032 · United States · LEI 54930055TH0ZLSAQMJ38
- Fund shareholders
- 248
- Of which ETFs
- 75 173 other funds
- Value held
- 326.7M $
- Share of capital
- 37.9 % of 42.5M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,126 | 22.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 1,104 | 22.3K $ | 0.79 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,089 | 23.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 1,017 | 19.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,014 | 20.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 1,003 | 19.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,000 | 19.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Value Tilt ETF SPDR SERIES TRUST | 918 | 18K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 877 | 17.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 839 | 16.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 824 | 16.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 766 | 15K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 747 | 15.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 746 | 16.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 731 | 14.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 695 | 13.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 552 | 10.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 518 | 10.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WisdomTree U.S. SmallCap Quality Growth Fund WisdomTree Trust | 483 | 9.5K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 448 | 9.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 432 | 8.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALLCAP VALUE ProFunds | 428 | 8.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 424 | 8.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 406 | 8.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Harbor AlphaEdge Small Cap Earners ETF Harbor ETF Trust | 391 | 8.6K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra SmallCap600 ProShares Trust | 388 | 7.8K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP SMALLCAP GROWTH ProFunds | 366 | 7.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 331 | 6.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF SPDR SERIES TRUST | 274 | 5.4K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 260 | 5.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 245 | 4.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 230 | 4.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 217 | 4.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 176 | 3.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF Pacer Funds Trust | 139 | 3.1K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 120 | 2.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP VALUE PROFUND ProFunds | 116 | 2.5K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 100 | 2.2K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 91 | 1.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 83 | 1.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 66 | 1.4K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 51 | 999.1 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 50 | 979.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 37 | 748.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 15 | 329.4 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 242.8 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 195.9 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 4 | 78.4 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 2.33 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.45 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.39 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.13 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.12 % | as of Apr 30, 2026 ↗ |
| M3Sixty Small Cap Growth Fund 360 Funds | 1.10 % | as of Feb 28, 2026 ↗ |
| Royce Capital Fund - Small-Cap Portfolio ROYCE CAPITAL FUND | 1.05 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Value Fund ROYCE FUND | 1.04 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 0.79 % | as of Feb 28, 2026 ↗ |
| Boston Trust Walden Small Cap Fund Boston Trust Walden Funds | 0.76 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 248 | +6 | 16,107,768 | +9.1 % |
| 2026Q1 | 242 | -6 | 14,760,571 | +2.5 % |
| 2025Q4 | 248 | +2 | 14,406,777 | -3.4 % |
| 2025Q3 | 246 | -18 | 14,915,152 | -5.5 % |
| 2025Q2 | 264 | -15 | 15,789,678 | -13.7 % |
| 2025Q1 | 279 | -4 | 18,297,805 | -1.7 % |
| 2024Q4 | 283 | +14 | 18,609,156 | +1.8 % |
| 2024Q3 | 269 | -14 | 18,276,651 | +1.0 % |
| 2024Q2 | 283 | -4 | 18,098,383 | -4.2 % |
| 2024Q1 | 287 | -20 | 18,887,338 | -3.8 % |
| 2023Q4 | 307 | 19,640,538 |
Institutional managers
206 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 5,421,343 | 106.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,027,947 | 39.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,607,515 | 31.5M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 1,541,044 | 30.2M $ | as of Mar 31, 2026 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,395,139 | 27.3M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,025,640 | 20.1M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,017,538 | 19.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 976,650 | 19.1M $ | as of Mar 31, 2026 |
| Boston Trust Walden Corp | 944,789 | 18.5M $ | as of Mar 31, 2026 |
| Epoch Investment Partners, Inc. | 898,895 | 17.6M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 665,542 | 13M $ | as of Mar 31, 2026 |
| LSV ASSET MANAGEMENT | 651,714 | 12.8K $ | as of Mar 31, 2026 |
| Invesco Ltd. | 604,774 | 11.8M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 553,900 | 10.9M $ | as of Mar 31, 2026 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 452,898 | 8.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 420,337 | 8.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 420,263 | 8.2M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 406,175 | 8M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 372,279 | 7.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 371,373 | 7.3M $ | as of Mar 31, 2026 |
| Bridge City Capital, LLC | 335,105 | 6.6M $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 330,457 | 6.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 329,388 | 6.5M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 325,291 | 6.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 321,039 | 6.3M $ | as of Mar 31, 2026 |
Funds holding the debt of Amphastar Pharmaceuticals Inc
12 funds declare 12 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Calamos Market Neutral Income Fund | 1 | 9.1M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 5M $ | as of Apr 30, 2026 |
| Miller Intermediate Bond Fund | 1 | 4.1M $ | as of Apr 30, 2026 |
| Miller Convertible Bond Fund | 1 | 3.8M $ | as of Apr 30, 2026 |
| Global Opportunities Portfolio | 1 | 2.7M $ | as of Apr 30, 2026 |
| Fidelity Convertible Securities Fund | 1 | 1.9M $ | as of Feb 28, 2026 |
| Multi-Asset Strategy Fund | 1 | 1.3M $ | as of Apr 30, 2026 |
| Fidelity Strategic Dividend and Income Fund | 1 | 898.7K $ | as of Feb 28, 2026 |
| Multi-Strategy Income Fund | 1 | 808.2K $ | as of Apr 30, 2026 |
| Advent Convertible Bond ETF | 1 | 346.4K $ | as of Feb 28, 2026 |
| Harbor Ares Systematic Convertible Securities Fund | 1 | 91.4K $ | as of Apr 30, 2026 |
| Franklin Alternative Strategies Fund | 1 | 32.9K $ | as of Feb 27, 2026 |
Cite this page
Titelia. "Fund shareholders of Amphastar Pharmaceuticals Inc". https://titelia.com/en/stocks/amphastar-pharmaceuticals-inc-US03209R1032